Single-cell Analysis Market | Growing at a CAGR of 17.8% | Increasing Incidence and Prevalence of Chronic and Infectious Diseases

Single-cell Analysis Market

Single-cell Analysis Market Single-cell Analysis Market

PUNE, India, 2020-Sep-29 — /EPR Network/ —

According to the new market research report “Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instruments), Technique (Flow Cytometry, NGS, PCR, Mass Spectrometry, Microscopy), Application (Research, Medical Application), End User – Global Forecasts to 2025″ published by MarketsandMarkets™.

The Single-cell Analysis Market is projected to reach USD 5.6 billion by 2025 from USD 2.1 billion in 2019, at a CAGR of 17.8% during the forecast period.

Major Market Growth Drivers:

  • Technological Advancements in Single-cell Analysis Products
  • Increasing Government Funding for Cell-Based Research
  • Growing Biotechnology and Biopharmaceutical Industries
  • Wide Applications of Single-cell Analysis in Cancer Research
  • Growing Focus on Personalized Medicine
  • Increasing Incidence and Prevalence of Chronic and Infectious Diseases

Browse 225 market data Tables and 50 Figures spread through 252 Pages and in-depth TOC | Request Research Sample Pages:

Research applications will continue to dominate the market during the forecast period

On the basis of application, the market is segmented into research (cancer, immunology, neurology, stem cell, and other research applications) and medical applications (noninvasive prenatal diagnosis, in vitro fertilization, and circulating tumor cell detection). The research applications segment accounted for the largest market share in 2018. Increasing government initiatives in stem cell research and the wide usage of single-cell analysis in cancer research are the major factors driving the growth of the research applications segment.

NGS is the fastest-growing segment of the single-cell analysis market.

Based on technique, the single cell analysis market is segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, and other techniques. The NGS segment is projected to register the highest growth rate of 20.0% during the forecast period. The high growth of the NGS segment is driven by the increasing application of single-cell analysis products in drug discovery for cancer and other chronic diseases.

Major Market Growth Opportunities:

  • High Growth Potential of Single-Cell Sequencing (SCS)
  • Growth in Stem Cell Research
  • Integration of Microfluidics in Single-cell Analysis

Download PDF Brochure:

The global market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is anticipated to witness the highest growth during the forecast period. The presence of a large patient population (especially in China and India), increasing investments in R&D, and growth in the outsourcing of drug discovery services to Asian CROs are some of the major factors driving the demand for single-cell analysis consumables and instruments in this regional market.

Key Market Players;

Prominent players in the single-cell analysis market are Becton, Dickinson and Company (US), Danaher Corporation (US), Merck Millipore (US), QIAGEN (Netherlands), Thermo Fisher Scientific (US), General Electric Company (US), 10x Genomics (US), Promega Corporation (US), Illumina (US), Bio-Rad Laboratories (US), Fluidigm Corporation (US), Agilent Technologies (US), NanoString Technologies (US), Tecan Group (Switzerland), Sartorius AG (Germany), Luminex Corporation (US), Takara Bio (Japan), Fluxion Biosciences (US), Menarini Silicon Biosystems (Italy), and LumaCyte (US).

Matched content

Editor’s pick

Express Press Release Distribution